Infectious Diseases (except HIV/AIDS)
-
Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19
This article has 7 authors:Reviewed by ScreenIT
-
Immune response elicited from heterologous SARS-CoV-2 vaccination: Sinovac (CoronaVac) followed by AstraZeneca (Vaxzevria)
This article has 7 authors:Reviewed by ScreenIT
-
Early versus late third trimester maternal SARS-CoV-2 BNT162b2 mRNA immunization maximizes transplacental antibody transfer and neonatal neutralizing antibody levels
This article has 8 authors:Reviewed by ScreenIT
-
Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US
This article has 4 authors:Reviewed by ScreenIT
-
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
This article has 10 authors:Reviewed by ScreenIT
-
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity
This article has 26 authors:Reviewed by ScreenIT
-
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine
This article has 6 authors:Reviewed by ScreenIT
-
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans
This article has 31 authors:Reviewed by ScreenIT
-
Total infectome characterization of respiratory infections in pre-COVID-19 Wuhan, China
This article has 17 authors:Reviewed by ScreenIT
-
Discrepancies in the detection of SARS-CoV-2 by qRT-PCR are dependent on the target gene used for its amplification: Implications in the diagnosis of clinical infection
This article has 8 authors:Reviewed by ScreenIT